Neuro-oncology: Gangliogliomas-what is the appropriate management strategy?

Nature Reviews Neurology

Volumn 6, Issue 4, 2010, Pages 190-191

  Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER INCIDENCE; GLIOMA; HUMAN; OVERALL SURVIVAL; PATIENT CARE PLANNING; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SHORT SURVEY; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; GANGLIOGLIOMA; HUMANS; NEUROSURGICAL PROCEDURES; RADIOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950841317     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.32     Document Type: Short Survey

References (7)

1. Lang, F. F. in Tumors of the Brain and Spine (eds Demonte, F., Gilbert, M. R., Mahajan, A. & McCutcheon, i. e.) 93-119 (springer-verlag, new York, 2007).
2. Giulioni, M. et al. Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J. Clin. Neurosci. 13, 529-535 (2006).
3. Rades, D. et al. The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer 116, 432-442 (2010).
4. Luyken, C. et al. supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101, 146-155 (2004).
5. im, s. H. et al. intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J. Neurooncol. 59, 173-183 (2002).
6. Karim, A. B., Afra, D. & Cornu, P. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: european Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: an interim analysis. Int. J. Radiat. Oncol. Biol. Phys. 52, 316-324 (2002).
7. van den Bent, M. J., Afra, D. & de witte, O. Longterm efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the eORTC 22845 randomised trial. Lancet 366, 985-990 (2005).